IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v16y2025i1d10.1038_s41467-025-60971-3.html
   My bibliography  Save this article

Cx43 enhances response to BRAF/MEK inhibitors by reducing DNA repair capacity

Author

Listed:
  • Adrián Varela-Vázquez

    (Universidade da Coruña (UDC), A Coruña, Spain)
    The Institute of Cancer Research)

  • Amanda Guitián-Caamaño

    (Universidade da Coruña (UDC), A Coruña, Spain)
    University College Dublin)

  • Paula Carpintero-Fernández

    (Universidade da Coruña (UDC), A Coruña, Spain))

  • Alexander Carneiro-Figueira

    (Universidade da Coruña (UDC), A Coruña, Spain))

  • Vanesa Álvarez

    (University of Dundee)

  • Marta Varela-Eirín

    (Universidade da Coruña (UDC), A Coruña, Spain))

  • Teresa Calleja-Chuclá

    (Universidade da Coruña (UDC))

  • Susana B. Bravo-López

    (Universidade de Santiago de Compostela (USC))

  • Anxo Vidal

    (Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS))

  • Juan Sendón-Lago

    (Universidade de Santiago de Compostela)

  • Marina Rodriguez-Candela Mateos

    (Universidade da Coruña (UDC))

  • José R. Caeiro

    (Universidade de Santiago de Compostela (USC))

  • Victoria Sanz-Moreno

    (The Institute of Cancer Research)

  • Trond Aasen

    (Autonomous University of Barcelona, CIBERONC)

  • Miguel G. Blanco

    (Universidade de Santiago de Compostela-Instituto de Investigación Sanitaria (IDIS))

  • Guadalupe Sabio

    (Universidade de Santiago de Compostela-Instituto de Investigación Sanitaria (IDIS))

  • María Quindós

    (Universidade da Coruña (UDC))

  • Carmen Rivas

    (Universidade de Santiago de Compostela
    Consejo Superior de Investigaciones Científicas (CSIC))

  • David Santamaría

    (Centro de Investigación del Cáncer, CSIC. University of Salamanca)

  • Carlos Fernandez-Lozano

    (Universidade da Coruna)

  • Eduardo Fonseca

    (Universidade da Coruña (UDC), A Coruña, Spain)
    Universidade da Coruña (UDC))

  • Pablo Huertas

    (Universidad de Sevilla-Consejo Superior de Investigaciones Científicas-Universidad Pablo de Olavide)

  • Berta Sánchez-Laorden

    (Consejo Superior de Investigaciones Científicas and Universidad Miguel Hernández)

  • Constance Alabert

    (University of Dundee)

  • María D. Mayán

    (Universidade da Coruña (UDC), A Coruña, Spain))

Abstract

BRAF and MEK inhibitors (BRAF/MEKi) have radically changed the treatment landscape of advanced BRAF mutation-positive tumours. However, limited efficacy and emergence of drug resistance are major barriers for successful treatments. Here, by using relevant preclinical models, we find that Connexin43 (Cx43), a protein that plays a role in cell-to-cell communication, enhances the effectiveness of BRAF/MEKi by recruiting DNA repair complexes to lamin-associated domains and promoting persistent DNA damage and cellular senescence. The nuclear compartmentalization promoted by Cx43 contributes to genome instability and synthetic lethality caused by excessive DNA damage, which could provide a therapeutic approach for these tumours to overcome drug resistance. Based on these findings, we designed a drug combination using small extracellular vesicles (sEVs) to deliver the full-Cx43 in combination with the BRAF/MEKi. This study reveals Cx43 as a regulator of DNA repair and BRAF/MEKi response, highlighting the therapeutic potential that this approach could eventually have in the clinic to overcome the limitations of current therapies and improve treatment outcomes for patients with advanced BRAF mutant tumours.

Suggested Citation

  • Adrián Varela-Vázquez & Amanda Guitián-Caamaño & Paula Carpintero-Fernández & Alexander Carneiro-Figueira & Vanesa Álvarez & Marta Varela-Eirín & Teresa Calleja-Chuclá & Susana B. Bravo-López & Anxo V, 2025. "Cx43 enhances response to BRAF/MEK inhibitors by reducing DNA repair capacity," Nature Communications, Nature, vol. 16(1), pages 1-20, December.
    • Handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-60971-3
    DOI: 10.1038/s41467-025-60971-3
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-025-60971-3
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-025-60971-3?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Maria Kotini & Elias H. Barriga & Jonathan Leslie & Marc Gentzel & Verena Rauschenberger & Alexandra Schambony & Roberto Mayor, 2018. "Author Correction: Gap junction protein Connexin-43 is a direct transcriptional regulator of N-cadherin in vivo," Nature Communications, Nature, vol. 9(1), pages 1-1, December.
    2. Helen Davies & Graham R. Bignell & Charles Cox & Philip Stephens & Sarah Edkins & Sheila Clegg & Jon Teague & Hayley Woffendin & Mathew J. Garnett & William Bottomley & Neil Davis & Ed Dicks & Rebecca, 2002. "Mutations of the BRAF gene in human cancer," Nature, Nature, vol. 417(6892), pages 949-954, June.
    3. Maria Kotini & Elias H. Barriga & Jonathan Leslie & Marc Gentzel & Verena Rauschenberger & Alexandra Schambony & Roberto Mayor, 2018. "Gap junction protein Connexin-43 is a direct transcriptional regulator of N-cadherin in vivo," Nature Communications, Nature, vol. 9(1), pages 1-17, December.
    4. Mandar Deepak Muzumdar & Pan-Yu Chen & Kimberly Judith Dorans & Katherine Minjee Chung & Arjun Bhutkar & Erin Hong & Elisa M. Noll & Martin R. Sprick & Andreas Trumpp & Tyler Jacks, 2017. "Survival of pancreatic cancer cells lacking KRAS function," Nature Communications, Nature, vol. 8(1), pages 1-19, December.
    5. Surya Shrivastava & Roslyn M. Ray & Leo Holguin & Lilliana Echavarria & Nicole Grepo & Tristan A. Scott & John Burnett & Kevin V. Morris, 2021. "Exosome-mediated stable epigenetic repression of HIV-1," Nature Communications, Nature, vol. 12(1), pages 1-14, December.
    6. Chen Yang & Chengzhe Tian & Timothy E. Hoffman & Nicole K. Jacobsen & Sabrina L. Spencer, 2021. "Melanoma subpopulations that rapidly escape MAPK pathway inhibition incur DNA damage and rely on stress signalling," Nature Communications, Nature, vol. 12(1), pages 1-14, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Palistha Shrestha & Jeevan Kandel & Hilal Tayara & Kil To Chong, 2024. "Post-translational modification prediction via prompt-based fine-tuning of a GPT-2 model," Nature Communications, Nature, vol. 15(1), pages 1-13, December.
    2. Josefine Radke & Elisa Schumann & Julia Onken & Randi Koll & Güliz Acker & Bohdan Bodnar & Carolin Senger & Sascha Tierling & Markus Möbs & Peter Vajkoczy & Anna Vidal & Sandra Högler & Petra Kodajova, 2022. "Decoding molecular programs in melanoma brain metastases," Nature Communications, Nature, vol. 13(1), pages 1-24, December.
    3. Hui Xiao & Jessica Shiu & Chi-Fen Chen & Jie Wu & Peijie Zhou & Sahil S. Telang & Rolando Ruiz-Vega & Robert A. Edwards & Qing Nie & Arthur D. Lander & Anand K. Ganesan, 2025. "Uncovering minimal pathways in melanoma initiation," Nature Communications, Nature, vol. 16(1), pages 1-17, December.
    4. Jiaxin Liang & Deyang Yu & Chi Luo & Christopher Bennett & Mark Jedrychowski & Steve P. Gygi & Hans R. Widlund & Pere Puigserver, 2023. "Epigenetic suppression of PGC1α (PPARGC1A) causes collateral sensitivity to HMGCR-inhibitors within BRAF-treatment resistant melanomas," Nature Communications, Nature, vol. 14(1), pages 1-12, December.
    5. Jasmeen Oberoi & Xavi Aran Guiu & Emily A. Outwin & Pascale Schellenberger & Theodoros I. Roumeliotis & Jyoti S. Choudhary & Laurence H. Pearl, 2022. "HSP90-CDC37-PP5 forms a structural platform for kinase dephosphorylation," Nature Communications, Nature, vol. 13(1), pages 1-13, December.
    6. Justin A. Peruzzi & Taylor F. Gunnels & Hailey I. Edelstein & Peilong Lu & David Baker & Joshua N. Leonard & Neha P. Kamat, 2024. "Enhancing extracellular vesicle cargo loading and functional delivery by engineering protein-lipid interactions," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
    7. Chuan-Hsin Chang & Yue-Cune Chang, 2022. "Comparing the Therapeutic Efficacies of Lung Cancer: Network Meta-Analysis Approaches," IJERPH, MDPI, vol. 19(21), pages 1-20, November.
    8. repec:plo:pone00:0086194 is not listed on IDEAS
    9. Ming Yi & Ruoqing Zhu & Robert M Stephens, 2018. "GradientScanSurv—An exhaustive association test method for gene expression data with censored survival outcome," PLOS ONE, Public Library of Science, vol. 13(12), pages 1-28, December.
    10. Anastasia Samarkina & Markus Kirolos Youssef & Paola Ostano & Soumitra Ghosh & Min Ma & Beatrice Tassone & Tatiana Proust & Giovanna Chiorino & Mitchell P. Levesque & Sandro Goruppi & Gian Paolo Dotto, 2023. "Androgen receptor is a determinant of melanoma targeted drug resistance," Nature Communications, Nature, vol. 14(1), pages 1-19, December.
    11. Boyang Zhao & Yiyun Rao & Scott Leighow & Edward P. O’Brien & Luke Gilbert & Justin R. Pritchard, 2022. "A pan-CRISPR analysis of mammalian cell specificity identifies ultra-compact sgRNA subsets for genome-scale experiments," Nature Communications, Nature, vol. 13(1), pages 1-13, December.
    12. repec:plo:pone00:0025806 is not listed on IDEAS
    13. repec:plo:pone00:0219935 is not listed on IDEAS
    14. repec:plo:pcbi00:1003795 is not listed on IDEAS
    15. Hannah Schaefer & Albert Rübben & André Esser & Arturo Araujo & Oana-Diana Persa & Marike Leijs, 2022. "A distinct four-value blood signature of pyrexia under combination therapy of malignant melanoma with dabrafenib and trametinib evidenced by an algorithm-defined pyrexia score," PLOS ONE, Public Library of Science, vol. 17(8), pages 1-19, August.
    16. Eunyoung Park & Shaun Rawson & Anna Schmoker & Byeong-Won Kim & Sehee Oh & Kangkang Song & Hyesung Jeon & Michael J. Eck, 2023. "Cryo-EM structure of a RAS/RAF recruitment complex," Nature Communications, Nature, vol. 14(1), pages 1-11, December.
    17. Abhineet Ram & Michael Pargett & Yongin Choi & Devan Murphy & Carolyn Teragawa & Markhus Cabel & Nont Kosaisawe & Gerald Quon & John G. Albeck, 2025. "Deciphering the history of ERK activity from fixed-cell immunofluorescence measurements," Nature Communications, Nature, vol. 16(1), pages 1-18, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-60971-3. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.